Munshi Amit — SEC Form 4 filings
SEC reporting owner CIK 1612551. 15 Form 4 filings on record with FilingPulse; latest filed 2026-06-30.
Transaction summary — filings shown
Covers all 15 filings on record, filed 2024-04-24 to 2026-06-30. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 2 legs across 2 filings — 524,744 shares, $1,000,049 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 18.
- Largest priced transaction: purchase of 365,000 shares @ $1.37 ($500,050) in Inhibikase Therapeutics, Inc., filed 2024-10-23.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Inhibikase Therapeutics, Inc. (IKT) | Director | 6 | 1 leg · 365,000 sh · $500,050 | — | 7 |
| Zura Bio Ltd (ZURA) | Director | 5 | 1 leg · 159,744 sh · $499,999 | — | 4 |
| Arcutis Biotherapeutics, Inc. (ARQT) | Director | 2 | — | — | 5 |
| Galecto, Inc. (GLTO) | Director | 2 | — | — | 2 |
Form 4 filings — Munshi Amit
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-30 | 4 | Inhibikase Therapeutics, Inc. (IKT) | Grant/award (A): 155,000 (derivative) @ $0 | EDGAR |
| 2026-06-22 | 4 | Zura Bio Ltd (ZURA) | Grant/award (A): 51,000 (derivative) @ $0 | EDGAR |
| 2026-06-09 | 4 | Arcutis Biotherapeutics, Inc. (ARQT) | Grant/award (A): 5,778 @ $0 · Grant/award (A): 16,667 (derivative) @ $0 | EDGAR |
| 2026-02-24 | 4 | Inhibikase Therapeutics, Inc. (IKT) | Disposition to issuer (D): 19,089 @ $0 | EDGAR |
| 2025-12-08 | 4 | Arcutis Biotherapeutics, Inc. (ARQT) | Grant/award (A): 2,021 @ $0 · Grant/award (A): 16,502 (derivative) @ $0 · Grant/award (A): 6,177 (derivative) @ $0 | EDGAR |
| 2025-08-28 | 4 | Inhibikase Therapeutics, Inc. (IKT) | Grant/award (A): 57,265 @ $0 | EDGAR |
| 2025-07-02 | 4 | Inhibikase Therapeutics, Inc. (IKT) | Grant/award (A): 108,176 (derivative) @ $0 | EDGAR |
| 2025-06-20 | 4 | Galecto, Inc. (GLTO) | Grant/award (A): 720 (derivative) @ $0 | EDGAR |
| 2025-05-22 | 4 | Zura Bio Ltd (ZURA) | Grant/award (A): 51,000 (derivative) @ $0 | EDGAR |
| 2025-02-19 | 4 | Inhibikase Therapeutics, Inc. (IKT) | Grant/award (A): 56,600 (derivative) @ $0 · Grant/award (A): 116,585 (derivative) @ $0 | EDGAR |
| 2024-12-11 | 4 | Zura Bio Ltd (ZURA) | Grant/award (A): 117,000 (derivative) @ $0 | EDGAR |
| 2024-10-23 | 4 | Inhibikase Therapeutics, Inc. (IKT) | Purchase (P): 365,000 @ $1.37 · Grant/award (A): 60,000 (derivative) @ $0 | EDGAR |
| 2024-09-06 | 4/A | Zura Bio Ltd (ZURA) | Grant/award (A): 159,744 @ $3.13 | EDGAR |
| 2024-06-21 | 4 | Galecto, Inc. (GLTO) | Grant/award (A): 18,000 (derivative) @ $0 | EDGAR |
| 2024-04-24 | 4 | Zura Bio Ltd (ZURA) | Purchase (P): 159,744 @ $3.13 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1612551 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →